Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - large image1
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image1
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image2
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image3
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image4
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image5
Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum buy - image6

Factory Competitive Price Lyophilized Raw Peptide Retatrutide Tirzepatide Adipotide For Slimming Lab Study For Research Use Only, Not for Human Consum

2102 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

China

Packaging:

5mg/vial,10mg/vial,15mg/vial

Price valid (until):

2026-08-28

The product will be displayed normally on the website later.
Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



     

       Product Detail  

     


    Tirzepatide is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels. Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes.

    NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.

    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 1
    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 2

    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 3


    Items Specifications
    Product Name Tirzepatide
    CAS number 2023788-19-2
    Formula C225H348N48O68
    Appearance White powder
    Storage Dry and Cool Place

    Peptide Storage Guidelines: General Tips

    When storing peptides, remember to:
    • Store peptide in a cold, dry, dark place
    • Avoid repeated freezing and thawing of peptide
    • Avoid overexposure to the air
    • Avoid light exposure
    • Avoid storing peptides in solution long term
    • Aliquot peptide according to experimental requirements

    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 4 Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 5
    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 6


     

    Shipping Method    

     


    Shop CQ Chemical Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 7


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Pharmaceutical Peptide,Cosmetic peptide

    Location:

    Hong Kong

    Year of Establishment:

    2026

  • Inquiry History
    2102 Inquiries
    Country Product Purchase Quantity Date Posted
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.